Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 4/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | TEAD3 | Q99594 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21344787 | 0.84 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1MAOBTDP1SLC1A1 | |
| SCHEMBL2437269 | 0.82 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2SLC1A1TSHR | |
| SCHEMBL6378583 | 0.82 | ALDH1A1 (0.54) | ALDH1A1SMN1; SMN2SLC1A1TSHR | |
| SCHEMBL10158741 | 0.81 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2L3MBTL1MAOBTDP1 | |
| SCHEMBL28461120 | 0.81 | ALDH1A1 (0.61) | ALDH1A1NAAASMN1; SMN2L3MBTL1TEAD3 | |
| SCHEMBL24827422 | 0.78 | ALDH1A1 (0.57) | ALDH1A1L3MBTL1SLC1A1TSHRMAPK1 | |
| SCHEMBL5930158 | 0.78 | ALDH1A1 (0.57) | ALDH1A1HTTSMN1; SMN2L3MBTL1TDP1 | |
| SCHEMBL3413225 | 0.78 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2L3MBTL1TDP1SLC1A1 | |
| SCHEMBL31421978 | 0.78 | TLR2 (0.50) | TLR2PLA2G10PLA2G2A | |
| SCHEMBL29344721 | 0.77 | TSHR (0.47) | NAAAHTTSMN1; SMN2L3MBTL1TEAD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238212-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238212-A1 | LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS | CETP, NPC1, LCAT | ALDH1A1 4264/4885NAAA 375/4885HTT 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.